JP2013537240A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537240A5
JP2013537240A5 JP2013529411A JP2013529411A JP2013537240A5 JP 2013537240 A5 JP2013537240 A5 JP 2013537240A5 JP 2013529411 A JP2013529411 A JP 2013529411A JP 2013529411 A JP2013529411 A JP 2013529411A JP 2013537240 A5 JP2013537240 A5 JP 2013537240A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
hydroxy
alkoxy
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013529411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013537240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/052318 external-priority patent/WO2012040177A1/en
Publication of JP2013537240A publication Critical patent/JP2013537240A/ja
Publication of JP2013537240A5 publication Critical patent/JP2013537240A5/ja
Pending legal-status Critical Current

Links

JP2013529411A 2010-09-20 2011-09-20 糖尿病および脂質異常症の処置のための方法および組成物 Pending JP2013537240A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38444610P 2010-09-20 2010-09-20
US61/384,446 2010-09-20
PCT/US2011/052318 WO2012040177A1 (en) 2010-09-20 2011-09-20 Methods and compositions for treatment of diabetes and dyslipidemia

Publications (2)

Publication Number Publication Date
JP2013537240A JP2013537240A (ja) 2013-09-30
JP2013537240A5 true JP2013537240A5 (US20080242721A1-20081002-C00053.png) 2014-10-23

Family

ID=45818296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013529411A Pending JP2013537240A (ja) 2010-09-20 2011-09-20 糖尿病および脂質異常症の処置のための方法および組成物

Country Status (13)

Country Link
US (2) US8623897B2 (US20080242721A1-20081002-C00053.png)
EP (1) EP2618824A4 (US20080242721A1-20081002-C00053.png)
JP (1) JP2013537240A (US20080242721A1-20081002-C00053.png)
KR (1) KR20140009125A (US20080242721A1-20081002-C00053.png)
CN (1) CN103327974A (US20080242721A1-20081002-C00053.png)
AU (1) AU2011305610A1 (US20080242721A1-20081002-C00053.png)
BR (1) BR112013008675A2 (US20080242721A1-20081002-C00053.png)
CA (1) CA2812109A1 (US20080242721A1-20081002-C00053.png)
MX (1) MX2013003078A (US20080242721A1-20081002-C00053.png)
RU (1) RU2013118021A (US20080242721A1-20081002-C00053.png)
SG (1) SG188996A1 (US20080242721A1-20081002-C00053.png)
WO (1) WO2012040177A1 (US20080242721A1-20081002-C00053.png)
ZA (1) ZA201301936B (US20080242721A1-20081002-C00053.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040177A1 (en) * 2010-09-20 2012-03-29 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
US20140121267A1 (en) * 2011-09-20 2014-05-01 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia
WO2014162320A2 (en) * 2013-04-04 2014-10-09 Sphaera Pharma Pvt. Ltd. Novel analogues of epicatechin and related polyphenols
US9827222B2 (en) 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
JP6633609B2 (ja) * 2014-03-20 2020-01-22 エスペリオン・セラピューティクス・インコーポレイテッドEsperion Therapeutics, Inc. 肝疾患および他の医学的障害の処置のためのカルボキシ−シクロプロピルウンデカノール化合物
CA2978204A1 (en) 2015-03-13 2016-09-22 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
CN107118098B (zh) * 2016-02-25 2020-07-14 中国科学院上海药物研究所 一类脂肪酸类化合物、其制备方法及其用途
EP3618821A4 (en) * 2017-01-31 2021-03-03 Emory University MANAGEMENT OF NEPHROGENIC DIABETES INSIPIDUS

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280169A (en) * 1962-09-18 1966-10-18 Union Carbide Corp Sulfo-substituted aromatic dicarboxylic compounds
US3773946A (en) 1969-09-02 1973-11-20 Parke Davis & Co Triglyceride-lowering compositions and methods
US3853951A (en) * 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
IL64542A0 (en) 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
DE3423166A1 (de) 1984-06-22 1986-01-02 Epis S.A., Zug Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
JPS63246351A (ja) * 1987-04-02 1988-10-13 Rikagaku Kenkyusho ポリケト−ル系化合物及びその合成法
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
FR2740135B1 (fr) 1995-10-20 1997-12-19 Roussel Uclaf Nouveaux derives de pyrazoles acides, leur procede de preparation, leur application a titre de medicaments, leur nouvelle utilisation et les compositions pharmaceutiques les renfermant
IL119971A (en) 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
JPH10273469A (ja) * 1997-02-03 1998-10-13 Takeda Chem Ind Ltd 2環性キノン誘導体、製造法および剤
DE19837620A1 (de) 1997-08-22 1999-02-25 Novartis Ag Organische Verbindungen
AU751573C (en) 1998-03-27 2003-10-09 Janssen Pharmaceutica N.V. HIV inhibiting pyrimidine derivatives
KR100643419B1 (ko) 1998-03-27 2006-11-10 얀센 파마슈티카 엔.브이. Hiv를 억제하는 피리미딘 유도체
US6387897B1 (en) 1998-06-30 2002-05-14 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
JP2002526528A (ja) 1998-10-07 2002-08-20 ジョージタウン ユニヴァーシティー 単量体およびニ量体の複素環、ならびにその治療的使用
EP1130469A1 (en) 2000-02-22 2001-09-05 Lucent Technologies Inc. A radiation-sensitive resist material and a process for device fabrication using the same
DE10010430A1 (de) 2000-03-03 2001-09-06 Bayer Ag Substituierte 5-Ethyl-dihydropyridazinone und ihre Verwendung
MXPA03003020A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de cetona y composiciones para el control del colesterol y usos relacionados.
US6905525B2 (en) 2001-04-02 2005-06-14 Ciba Specialty Chemicals Corporation Candle wax stabilized with piperazinones
US6547840B2 (en) 2001-04-02 2003-04-15 Ciba Specialty Chemicals Corporation Candle wax stabilized with imidazolidines
US6544304B2 (en) 2001-04-02 2003-04-08 Ciba Specialty Chemicals Corporation Candle wax stabilized with morpholinones
US6562084B2 (en) 2001-04-02 2003-05-13 Ciba Specialty Chemicals Corporation Candle wax stabilized with piperazindiones
US6544305B2 (en) 2001-04-02 2003-04-08 Ciba Specialty Chemicals Corporation Candle wax stabilized with piperazinones
US6540795B2 (en) 2001-04-02 2003-04-01 Ciba Specialty Chemicals Corporation Candle wax stabilized with oxazolidines
JP2004523638A (ja) 2001-04-02 2004-08-05 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド 安定化したロウソクのロウ
CA2468529C (en) * 2001-10-09 2011-03-01 Kyorin Pharmaceutical Co., Ltd. 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
US20040082641A1 (en) 2002-10-28 2004-04-29 Rytved Klaus Asger Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
US7335799B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
CA2549995C (en) * 2003-12-24 2011-11-15 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
WO2005068410A1 (en) 2003-12-24 2005-07-28 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
FR2903695B1 (fr) * 2006-07-13 2008-10-24 Merck Sante Soc Par Actions Si Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL181577A0 (en) * 2007-02-26 2007-07-04 Jacob Bar Tana Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
JP5345293B2 (ja) 2007-03-29 2013-11-20 株式会社Adeka 重合性化合物及び重合性組成物
WO2009039937A1 (en) 2007-09-25 2009-04-02 Merck Patent Gmbh Mesogenic dimers
WO2012040177A1 (en) * 2010-09-20 2012-03-29 Kareus Therapeutics, Sa Methods and compositions for treatment of diabetes and dyslipidemia

Similar Documents

Publication Publication Date Title
JP2013537240A5 (US20080242721A1-20081002-C00053.png)
RU2012105467A (ru) Триазолопиридиновое соединение и его действие в качестве ингибитора пролилгидроксилазы и индуктора выработки эритропоэтина
JP2016516043A5 (US20080242721A1-20081002-C00053.png)
JP2017511321A5 (US20080242721A1-20081002-C00053.png)
JP2014506907A5 (US20080242721A1-20081002-C00053.png)
WO2015017813A3 (en) Inhibitors of the farnesoid x receptor and uses in medicine
JP2011513305A5 (US20080242721A1-20081002-C00053.png)
JP2011037841A5 (US20080242721A1-20081002-C00053.png)
JP2012513416A5 (US20080242721A1-20081002-C00053.png)
EP2581376A4 (en) MATRIC ACID / MATRIN DERIVATIVES AND MANUFACTURING METHOD AND USES THEREOF
NZ598085A (en) Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
JP2011504903A5 (US20080242721A1-20081002-C00053.png)
JP2014508811A5 (US20080242721A1-20081002-C00053.png)
JP2012512907A5 (US20080242721A1-20081002-C00053.png)
JP2009120598A5 (US20080242721A1-20081002-C00053.png)
JP2015535847A5 (US20080242721A1-20081002-C00053.png)
JP2012506443A5 (US20080242721A1-20081002-C00053.png)
JP2014534981A5 (US20080242721A1-20081002-C00053.png)
JP2016503797A5 (US20080242721A1-20081002-C00053.png)
RU2013118021A (ru) Способы и композиции для лечения сахарного диабета и дислипидемии
JP2018502101A5 (US20080242721A1-20081002-C00053.png)
JP2014510147A5 (US20080242721A1-20081002-C00053.png)
JP2013533253A5 (US20080242721A1-20081002-C00053.png)
RU2013136895A (ru) Новое бициклическое соединение или его соль
JP2017511368A5 (US20080242721A1-20081002-C00053.png)